| Title: | Amended And Restated Executive Employment Agreement |
| Contract Category: | Executive Employment Agreement |
| Summary: | This Amended And Restated Executive Employment Agreement, dated April 15, 2020, between a Delaware corporation and an individual, outlines the terms of employment for the individual as Chief Executive Officer, including compensation, duties, and termination provisions. |
| Governing Law: | Washington |
| Filer: | Neoleukin Therapeutics, Inc. (NLTX) |
| Parties: | Neoleukin Therapeutics, Inc. Jonathan G. Drachman, MD |
| Filing Date: | April 16, 2020 |
| SEC File / Film Number: | 001-36327 / 20797411 |
Options:
Show More
